ipamorelin and cjc 1295 results Sermorelin vs. CJC-1295 vs. The Strongest Peptide for Building

The recommended dose is 0.5mL (100mg GSH) per injection up to five (5) times per week

Lei Y, Xu Z, Ke Q, Yin W, Chen Y, Zhang C

CJC-1295 Side Effects and Complications In clinical applications, CJC-1295 administration occassionally produces reactions at the injection site and a range of mild to moderate side effects, such as [15, 16]: Rapid heartbeat Headaches Abdominal discomfort Facial flushing Loose stools Nausea It is crucial to acknowledge that this peptide has not been authorized for human use by the United States Food and Drug Administration or comparable regulatory body, and its safety profile has not been extensively studied in large-scale clinical trials

Packer M, Zile MR, Kramer CM, Baum SJ, Litwin SE, Menon V, et al